Role of pharmacogenetics of immunosuppressive drugs in organ transplantation.
about
Relationship of CYP3A5 genotype and ABCB1 diplotype to tacrolimus disposition in Brazilian kidney transplant patientsAssociation of MDR1 gene SNPs and haplotypes with the tacrolimus dose requirements in Han Chinese liver transplant recipients.Influence of Absorption, Distribution, Metabolism, and Excretion Genomic Variants on Tacrolimus/Sirolimus Blood Levels and Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.Effect of cytokine and pharmacogenomic genetic polymorphisms in transplantationImpact of ATP-binding cassette, subfamily B, member 1 pharmacogenetics on tacrolimus-associated nephrotoxicity and dosage requirements in paediatric patients with liver transplant.Pharmacogenetics and individualized therapy in children: immunosuppressants, antidepressants, anticancer and anti-inflammatory drugs.Genetics and nonmelanoma skin cancer in kidney transplant recipients.Mycophenolate revisited.Population Pharmacokinetic Modelling and Bayesian Estimation of Tacrolimus Exposure: Is this Clinically Useful for Dosage Prediction Yet?Influence of combined CYP3A4 and CYP3A5 single-nucleotide polymorphisms on tacrolimus exposure in kidney transplant recipients: a study according to the post-transplant phase.Population pharmacokinetics and pharmacogenetics of tacrolimus in de novo pediatric kidney transplant recipients.Long-term effects of ABCB1 and SXR SNPs on the systemic exposure to cyclosporine in pediatric kidney transplant patients.Influence of CYP3A and ABCB1 polymorphisms on cyclosporine concentrations in renal transplant recipients.A drug transporter for all ages? ABCB1 and the developmental pharmacogenetics of cyclosporine.
P2860
Q34065305-2D9E8A1F-A32D-447E-83BD-ADA1B765A013Q34081393-47A86239-B257-47CE-A25F-4B623924F3FFQ36474050-FB14CD5C-583B-4868-8E99-A0EBF9603BF3Q37244838-C93F1B0B-DC0E-4DCB-80F4-17CF179AE24FQ37772515-5A86BB3B-6B36-4A29-B03F-67C9968CDDC4Q37892531-BD4DABD0-5662-4474-8BDC-B6F896019B7FQ38330222-989989E3-98A0-441B-9D4E-A3ADE2C2A046Q38373106-CFD4743D-E266-4B93-8C00-43F127EF0CF9Q38809767-D391E5A9-2FD5-434A-986B-ABF1EA498B3BQ40265172-3314B820-19EF-4A90-9E17-4D44653199BCQ43253108-CF401A0E-1675-4E97-8008-A38C371C1469Q44839090-0B6E4336-9419-4E37-90B6-71DA89427B01Q49792894-8B4A5DC3-1ED8-4205-87AF-72F171517562Q51955888-9F272DF7-C6ED-4614-9870-DAF3956E18C2
P2860
Role of pharmacogenetics of immunosuppressive drugs in organ transplantation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of pharmacogenetics of immunosuppressive drugs in organ transplantation.
@en
Role of pharmacogenetics of immunosuppressive drugs in organ transplantation.
@nl
type
label
Role of pharmacogenetics of immunosuppressive drugs in organ transplantation.
@en
Role of pharmacogenetics of immunosuppressive drugs in organ transplantation.
@nl
prefLabel
Role of pharmacogenetics of immunosuppressive drugs in organ transplantation.
@en
Role of pharmacogenetics of immunosuppressive drugs in organ transplantation.
@nl
P2093
P1476
Role of pharmacogenetics of immunosuppressive drugs in organ transplantation
@en
P2093
Christophe Legendre
Dany Anglicheau
Eric Thervet
P304
P356
10.1097/FTD.0B013E31816BABEF
P577
2008-04-01T00:00:00Z